Bausch Health Companies Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Bausch Health Companies Inc's ROI in the second quarter of 2026?
Bausch Health Companies Inc had a negative return on investment (ROI) of -4.65%, due to the net loss of $-1 billion, during the twelve months ending in the second quarter of 2026.

Within the Healthcare sector 217 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1119 to 2891.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-3.28 %	7.18 %	14.04 %	10.4 %	6.58 %
Y / Y Net Income Change TTM	-	-	2300 %	-	-
Investment (TTM) in Millions	20,250	23,550	25,069	25,121	26,197
Return On Investment (TTM)	-4.65 %	-4.9 %	0.47 %	1.28 %	0.2 %
BHC's Overall Ranking	# 2891	# 1119	# 1887	# 821	# 2083
Seq. Investment Change TTM	-5.95 %	-2.44 %	2.41 %	2.93 %	4.22 %
Seq. Net Income Change TTM	-	-	-62.62 %	568.75 %	-
Net Income (TTM) in Millions	-1,093	-1,225	120	321	48

BHC Company Profile >> Back to BHC Roi Comparisons >> See Annual BHC Return On Investment

Return On Investment BHC's Ranking
Within:	No.
Industry	# 74
Sector	# 218
Overall	# 2891

Return On Investment Statistics
High	Average	Low
17.93 %	-0.51 %	-13.21 %
(Sep 30 2014)		(Dec 31 2018)

News about Bausch Health Companies Inc Return on Investment ROI

Bausch Healths Ongoing Struggles A Cautionary Tale of Debt and Market Sentiment

July 26, 2024

The recent performance of Bausch Health Companies Inc., which has lagged behind the broader market by nearly 17.89% so far this year, reflects a multitude of factors, from financial instability to persistent rumors of bankruptcy. After suffering a staggering decline of over 40% in stock value amidst swirling speculation regarding its financial health, Bausch Health s management was compelled to intervene by denying these bankruptcy claims. However, the damage was done, and the company’s stock ultimately settled with losses around 20% for that day. Bausch Health, a name synonymous with a tumultuous history that includes accounting scandals and a slew of management challenges, finds itself in the eye of the storm once again. The company s woes are not new; prior struggles with debt have led to increased scrutiny from analysts and investors alike, jeopardizing its position within the healthcare sector.The most recent distress signals emanated from reports suggesting that Bausch Health was negotiating a potential prepackaged Chapter 11 bankruptcy in order to alleviate its considerable debt burden. Such alarming news translated into an immediate 44% drop in stock price, sending shares plummeting to a 19-year low. Adding fuel to the fire, analysts have noted that within the healthcare sector, there are 171 other companies boasting better returns on investment (ROI) than Bausch Health, which reported a staggering cumulative net loss of $479 million during the 12 months ending in the first quarter of 2024. This translates to a negative ROI of -2.04%, culminating in a dismal overall ranking in the sector.

Financial Statements
Bausch Health Companies Inc's II. Quarter Investments	$ 20,250 Millions	BHC's Balance sheet
Bausch Health Companies Inc's II. Quarter Income	$ 260 Millions	Quarterly BHC's Income Statement
BHC's Income by Division		See BHC's Income by Division

BHC Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	22,205	22,662	23,442	21,863	24,850
Y / Y Investment Growth	-2.02 %	-3.33 %	7.22 %	-12.02 %	-8.86 %
Net Income in Millions	120	-72	-611	-212	-937
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	0.54 %	-0.32 %	-2.61 %	-0.97 %	-3.77 %

Annual Roi Comment

In the fiscal year 2025 ROI improved to 0.54 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BHC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BHC's Competitors
Subscribers only: Roi for Bausch Health Companies Inc's Suppliers
Subscribers only: Return On Investment for BHC's Customers

Other Ratios
BHC's Roa	BHC's Inventory Turnover Ratio	BHC's Growth Rates	BHC's Dividend Statistics
	BHC's Profitability Ratios	BHC's Asset Turnover Ratio	BHC's Dividend Growth
BHC's Roe	BHC's Valuation Ratios	BHC's Financial Strength Ratios	BHC's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-15T07:25:10+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.